VEGF, the main proangiogenic molecule, is responsible for excessive angiogenic response within the tumor tissue, and antiangiogenic therapies directed against this molecule or its receptors result in the normalization of the blood vessel network [40]. This evidence concerns the gene VEGFA and neoplasm.